Nursing home use up with cognitive impairment category

October 1, 2017

(HealthDay)—Nursing home (NH) use increases with increasing cognitive impairment category, according to a study published online Sept. 11 in the Journal of the American Geriatrics Society.

Jane A. Emerson, from the Mayo Clinic in Rochester, Minnesota, and colleagues estimated NH use among 3,545 Mayo Clinic Study of Aging participants (aged 70 to 89 years), assessed as cognitively normal (CN), (MCI), previously unrecognized , or prevalent dementia.

The researchers found that the percentages who died in the year after cognition was assessed were 1, 2.6, 4.2, and 21 percent among those categorized as CN, MCI, previously unrecognized dementia, and prevalent dementia, respectively. The percentages with any NH use were 3.8, 8.7, 19, and 40 percent, respectively, with 27, 38, 120, and 305 median NH days and 7.8, 12, 33, and 100 percent median percentages of NH days/days of observation, respectively. A significantly higher proportion had any NH use for each increase in cognitive impairment category. Individuals with prevalent dementia and any NH use had especially high one-year mortality (30 percent versus 13 percent for those with no NH use). Among those with prevalent dementia, 58 percent of all deaths occurred while an NH resident.

"Reductions in NH use could result from quality alternatives to NH admission, both among persons with MCI and persons with dementia, together with suitable options for end-of-life care among persons with prevalent dementia," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including AbbVie, which partially funded the study.

Explore further: Inappropriate med use high in cognitively impaired seniors

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Inappropriate med use high in cognitively impaired seniors

August 2, 2017
(HealthDay)—Many nursing home residents with cognitive impairment or dementia have potentially inappropriate medication (PIM) use, with PIM use more likely among frail individuals, according to a study published online ...

Low-dose aspirin no aid against cognitive decline

May 9, 2017
(HealthDay)—Low-dose aspirin does not protect against cognitive decline, according to a review published April 20 in the Journal of the American Geriatrics Society.

Personality changes don't precede clinical onset of Alzheimer's, study shows

September 21, 2017
For years, scientists and physicians have been debating whether personality and behavior changes might appear prior to the onset of Alzheimer's disease and related dementias.

Late-life depression associated with prevalent mild cognitive impairment, increased risk of dementia

December 31, 2012
Depression in a group of Medicare recipients ages 65 years and older appears to be associated with prevalent mild cognitive impairment and an increased risk of dementia, according to a report published Online First by Archives ...

Research finds increased risk of dementia in patients who experience delirium after surgery

July 28, 2017
Delirium is common in elderly hospitalized patients, affecting an estimated 14 - 56% of patients. It frequently manifests as a sudden change in behavior, with patients suffering acute confusion, inattention, disorganized ...

Review links albuminuria to cognitive impairment, dementia

February 13, 2017
(HealthDay)—Albuminuria is associated with cognitive impairment, dementia, and cognitive decline, according to a review published online Feb. 2 in the Journal of the American Geriatrics Society.

Recommended for you

PET scans for Alzheimer's could bring benefit to more patients

October 19, 2017
An imaging tool honed to spot rogue proteins in the brain could benefit some patients with suspected Alzheimer's, according to a new study.

One step closer toward a treatment for Alzheimer's disease?

October 18, 2017
Scientists at the Massachusetts General Hospital (MGH), in collaboration with colleagues at the University California, San Diego (UCSD), have characterized a new class of drugs as potential therapeutics for Alzheimer's disease ...

New mechanism detected in Alzheimer's disease

October 13, 2017
McGill University researchers have discovered a cellular mechanism that may contribute to the breakdown of communication between neurons in Alzheimer's disease.

Neuroscientists identify genetic changes in microglia in a mouse model of neurodegeneration and Alzheimer's disease

October 13, 2017
Microglia, immune cells that act as the central nervous system's damage sensors, have recently been implicated in Alzheimer's disease.

Green tea extract delivers molecular punch to disrupt formation of neurotoxic species

October 11, 2017
Green tea is widely considered to be beneficial for the brain. The antioxidant and detoxifying properties of green tea extracts help fight catastrophic diseases such as Alzheimer's. However, scientists have never fully understood ...

Menopause triggers metabolic changes in brain that may promote Alzheimer's

October 10, 2017
Menopause causes metabolic changes in the brain that may increase the risk of Alzheimer's disease, a team from Weill Cornell Medicine and the University of Arizona Health Sciences has shown in new research.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.